OpenVSafe by OpenVAERS
Search V-safe

E57-93660-37427

2 vaccinations 4 coded responses 17 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
995 / AK
Registered
2020-12-19
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-19
    Registered in v-safe
  2. 2020-12-19
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-19
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2020-12-26
    Survey response — day 7, dose 1
    MedDRA: Chest pain, Palpitations — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Chest pain, heart palpitations - experienced since 12/24
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2020-12-26
    Report sent to call center — day 7, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-01-03
    Survey response — day 14, dose 1
    MedDRA: Chest pain, Palpitations — Feeling: Good
    Free text: Chest pain and palpitations with exertion (i.e during exercise and when lifting patients in my role as a hospital-based physical therapist. These symptoms began on 12/24. Symptoms persist > 1 hour after the activity with rest
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-09
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-09
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  12. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  13. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Poor · Chills, Headache, Fatigue or tiredness, Nausea
    Adult check-in
  15. 2021-01-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-12
    Survey response — 6 months, dose 2
    MedDRA: Chills, Cough, Headache, Malaise, Pyrexia — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Cough lasting the past 3 weeks, low grade fever, chills, malaise, headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2022-01-09
    Survey response — 12 months, dose 2
    MedDRA: Nasopharyngitis, Oxygen saturation decreased, Tachycardia, Viral infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Viral infections, tachycardia and decreased oxygen saturation, cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-01-09
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  23. 2022-01-11
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12020-12-19Pfizer-BioNTech
22021-01-09Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 7, dose 1

2020-12-26

Systemic reaction (other): Chest pain, heart palpitations - experienced since 12/24

Release 1 — day 14, dose 1

2021-01-03

Symptoms: Chest pain and palpitations with exertion (i.e during exercise and when lifting patients in my role as a hospital-based physical therapist. These symptoms began on 12/24. Symptoms persist > 1 hour after the activity with rest

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Cough lasting the past 3 weeks, low grade fever, chills, malaise, headaches

Release 10 — 12 months, dose 2

2022-01-09

Symptoms: Viral infections, tachycardia and decreased oxygen saturation, cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain ✓ ✓ ✓
SDChills ✓ ✓ ✓
SDCough ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDMalaise ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDOxygen saturation decreased · · ✓
SDPalpitations ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDTachycardia · · ✓
SDViral infection · · ✓
SROChest pain ✓ ✓ ✓
SROPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release